86 filings
Page 2 of 5
8-K
09tfd7shrj8rhjbw7
8 Aug 23
Vigil Neuroscience Reports Second Quarter 2023 Financial Results and Provides Business Update
7:19am
8-K
51ky9mlxd
8 Jun 23
Submission of Matters to a Vote of Security Holders
5:12pm
8-K
jvff57
10 May 23
Vigil Neuroscience Reports First Quarter 2023 Financial Results and Provides Business Update
7:14am
DEFA14A
u5b870x9x
9 May 23
Additional proxy soliciting materials
8:42am
8-K
9k69vvw5a zdb6qrgxbw
9 May 23
Vigil Neuroscience Appoints Samantha Budd Haeberlein, Ph.D. to Board of Directors
8:15am
ARS
s1k ppno1yn7gpj4zwat
27 Apr 23
Annual report to shareholders
7:11am
DEFA14A
bkb21
27 Apr 23
Additional proxy soliciting materials
7:07am
EFFECT
zy57p4om078oublkp
31 Mar 23
Notice of effectiveness
12:15am
8-K
z4esev1xvc1jijat24
30 Mar 23
Vigil Neuroscience Announces FDA Has Lifted the Partial Clinical Hold on VGL101
7:10am
CORRESP
28d2518 qz
28 Mar 23
Correspondence with SEC
12:00am
UPLOAD
7ztes60
27 Mar 23
Letter from SEC
12:00am
S-8
u1t1w275gsy
21 Mar 23
Registration of securities for employees
9:17am
S-3
9sbdnzay25muxf
21 Mar 23
Shelf registration
7:53am
8-K
z968hcyqz qlkn
21 Mar 23
Vigil Neuroscience Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
7:09am
8-K
ljgdmn4g
10 Mar 23
Regulation FD Disclosure
3:34pm
UPLOAD
sqd1c6yrz3t
28 Feb 23
Letter from SEC
12:00am
8-K
zreqkld0p fyszngay
10 Feb 23
Departure of Directors or Certain Officers
4:05pm